DPPA5/ESG1 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # AF3125I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry, Western Blot
Label
Janelia Fluor 549
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human DPPA5/ESG1
Met1-Lys116
Accession # NP_001020461
Met1-Lys116
Accession # NP_001020461
Specificity
Detects human DPPA5/ESG1 in direct ELISAs and Western blots. In Western blots, approximately 40% cross-reactivity with recombinant mouse DPPA5 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for DPPA5/ESG1 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: DPPA5/ESG1
Long Name
Developmental Pluripotency Associated 5
Alternate Names
ESG1
Gene Symbol
DPPA5
Additional DPPA5/ESG1 Products
Product Documents for DPPA5/ESG1 Antibody [Janelia Fluor® 549]
Product Specific Notices for DPPA5/ESG1 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...